Form 4: SOPHiA GENETICS SA Executive Sells Shares
Insider Transaction (Form 4)
Manuela Valente, Chief People Officer of SOPHiA GENETICS SA, sold 10,000 shares of common stock on August 19, 2026 for $7.94 per share.
Summary
- Option exercise/conversion: acquired 10,000 Ordinary Shares at $3.20 ($32,000) on August 19, 2026; holds 220,450 after (Direct).
- Open-market sale: disposed of 10,000 Ordinary Shares at $7.94 ($79,439) on August 19, 2026; holds 210,450 after (Direct).
- Option exercise/conversion: disposed of 10,000 Share Option (Right to Buy) on August 19, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $79,439 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Manuela Valente — Officer (Chief People Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Option exercise/conversion | Ordinary Shares | 10,000 | $3 | $32.0K | 220,450 |
| 2026-08-19 | Open-market sale | Ordinary Shares | 10,000 | $8 | $79.4K | 210,450 |
| 2026-08-19 | Option exercise/conversion | Share Option (Right to Buy) | 10,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Option exercise/conversion (10,000 shares) |
| 2026-08-19 | Open-market sale (10,000 shares) |
| 2026-08-19 | Option exercise/conversion (10,000 shares) |
Keywords
insider transaction, Form 4, SOPH, SOPHiA GENETICS SA, bearish, Manuela Valente
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.